Access to care

Pediatric Blood and Cancer

Volumn 50, Issue 5 SUPPL., 2008, Pages 1094-1098

  Albritton, Karen H ^a   Eden, Tim ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Access; Cancer care

Indexed keywords

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ADULTHOOD; ATTITUDE TO HEALTH; CHILDHOOD CANCER; CLINICAL STUDY; CONFERENCE PAPER; DELAYED DIAGNOSIS; EARLY DIAGNOSIS; HEALTH CARE ACCESS; HUMAN; INTERNATIONAL COOPERATION; PATIENT CARE; PRIORITY JOURNAL; RESEARCH SUBJECT;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; AGE FACTORS; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; EARLY DIAGNOSIS; FEMALE; GOALS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; MALE; NEOPLASMS; PATIENT SELECTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41849108846     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21461     Document Type: Conference Paper

References (44)

1. Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast cancer symptoms: A retrospective analysis. Lancet 1999;353:1132-1135.
2. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999;353:1119-1126.
3. Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, et al. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg 2004;28:716-720.
4. Bacci G, Di Fiore M, Rimondini S, et al. Delayed diagnosis and tumor stage in Ewing's sarcoma. Oncol Rep 1999;6:465-466.
5. Goyal S, Roscoe J, Ryder WD, et al. Symptom interval in young people with bone cancer. Eur J Cancer 2004;40:2280-2286.
6. Moul JW, Paulson DF, Didge RK, et al. Delay in diagnosis and survival in testicular cancer: Impact of effective therapy and changes during 18 years. J Urol 1990;143:520-523.
7. Pears J, Eden T. Determinants of symptom interval in childhood leukaemia. 1995; Personal communication.
8. Saha V, Love S, Eden T, et al. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993;68:771-774.
9. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumours. J Pediatr 1991;119: 725-732.
10. Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer. A review. Cancer 2007;110:703-713.
11. Klein-Geltink J, Pogany L, Mery LS, et al. Impact of age and diagnosis on waiting times between important healthcare events among children 0-19 years cared for in pediatric units: The Canadian Childhood Cancer Surveillance and Control Program. J Pediatr Hematol Oncol 2006;28:433-439.
12. Klein-Geltink J, Shaw AK, Morrison HI, et al. Use of paediatric versus adult oncology treatment centres by adolescents 15-19 yeas old: The Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer 2005;41:404-410.
13. Summerfield GP, Carey PJ, Galloway MJ, et al. An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom. Clin Lab Haematol 2000;22:157-160.
14. Eden T, Rogers M, Barker L, et al. Symptom interval (SI) in teenage and young adults (TYA) with cancer. Pediatr Blood Cancer 2007;49:575 (abstr PS 016).
15. Smith S. Report from 'Find Your Sense of Tumour' conference 2007; personal communication.
16. Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 2000;82: 667-674.
17. Wurtz LD, Peabody TD, Simon MA. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am 1999;81:317-325.
18. Bleyer A, Ulrich C, Martin S, et al. Status of health insurance predicts time from symptom onset to cancer diagnosis in young adults. Proc Am Soc Clin Oncol 2005;23:547s.
19. Bleyer A, Montello M, Budd T, et al. National survival trends of young adults with sarcoma: Lack of progress is associated with lack of clinical trial participation. Cancer 2005;103:1891-1897.
20. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: Children have equal access; adolescents do not. J Adolesc Health 1997;21:336-373.
21. Stiller CA, Eatock EM. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Arch Dis Child 1999;81:202-208.
22. Stiller CA. Centralisation of treatment and survival rates of cancer. Arch Dis Child 1988;63:23-30.
23. Fern L, Whelan J. Percentage of children, young adults and older adults entered into trials across selected portfolios, 2005-2006; Personal communication.
24. Shochat SJ, Fremgen AM, Murphy SB, et al. Childhood cancer: Patterns of protocol participation in a national survey. CA Cancer J Clin 2001;51:119-130.
25. Benjamin S, Kroll ME, Cartwright RA, et al. Haematologists' approaches to the management of adolescents and young adults with acute leukaemia. Br J Haematol 2000;111:1045-1050.
26. Birch JM, Alston RD, Kelsey AM, et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002;87:1267-1274.
27. Alston RD, Rowan S, Eden TOB, et al. Cancer incidence patterns by region and socio-economic deprivation in teenagers and young adults in England. Br J Cancer 2007;97:1760-1766.
28. Bleyer A, Barr R, Ries LAG, editors. Cancer epidemiology in older adolescents and young adults 15-29 years of age: Including SEER incidence and survival: 1975-2000. Bethesda: National Cancer Institute; 2006.
29. Albritton KH, Wiggins CH, Nelson HE, et al. Site of oncologic care for older adolescents in Utah. J Clin Oncol 2007;25:4616-4621.
30. Rauck AM, Fremgen AM, Hutchinson CL, et al. Adolescent cancers in the United States: A National Cancer Database (NCDB) report. J Pediatr Hematol Oncol 1999;21:310. (abstr).
31. Kramer S, Meadows AT, Pastore G, et al. Influence of place of treatment on diagnosis, treatment and survival in three pediatric solid tumors. J Clin Oncol 1984;2:917-923.
32. Paulussen M, Ahrens S, Juergens HF. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies. Proc Am Soc Clin Oncol 2003;22:abstr 3279.
33. Stock W, Sather H, Didge RK. Outcome of adolescents and young adults with ALL: A comparison of Children's Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens. Blood 2000;96:467a.
34. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA -94 trials. J Clin Oncol 2003;21:774-7780.
35. De Bont JM, Holt B, Dekker AW, et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004;18:2032-2035.
36. Ramanujacher R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: Outcome on UK National Paediatric (ALL 97) and Adult (UKALL XII/E2993) Trials. Pediatr Blood Cancer 2007;48:254-261.
37. Testi AM, Valsecchi MG, Conter V, et al. Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols. Blood 2004;104:1954 (abstr).
38. Hallbrook H, Gustafsson G, Smedmyr B, et al. Treatment outcome in young adults and children > 10 years of age with acute lymphoblastic leukaemia in Sweden: A comparison between a pediatric protocol and an adult protocol. Cancer 2006;107:1551-1556.
39. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004;101:627-634.
40. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 2003;98:571-580.
41. Chessells JM, Hall E, Prentice HG, et al. The impact of age on outcome in lymphoblastic leukaemia: MRC UKALL X and XA compared: A report from the MRC paediatric and adult working parties. Leukemia 1998;12:463-473.
42. Zebreck B, Bleyer A, Albritton K, et al. Assessing the health care needs of adolescent and young adult cancer patients and survivors. Cancer 2006;107:2915-2923.
43. National Institute for Health and Clinical Excellence. Improving outcomes for children and young people with cancer. The evidence review, 2005. http://www.nice.org.uk/pdf/c&ypevidencereview.pdf and NICE improving outcomes the manual 2005; http://www.nice.org.uk/pdf/C&YPmanual.pdf.
44. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer Report of the Adolescent and Young Adult Oncology Progress Review Group. US Department of Health and Human Services, 2006.